Antibody‐enhanced hepatitis E virus nanofiltration during the manufacture of human immunoglobulin

Probable transmission of hepatitis E virus (HEV) via transfusion in the United States

(2019) John R. Ticehurst et al.   TRANSFUSION

Systematic review and meta-analysis of the seroprevalence of hepatitis E virus in the general population across non-endemic countries

(2019) Barbara Wilhelm et al.   PLoS One

Hepatitis E Virus Lifecycle and Identification of 3 Forms of the ORF2 Capsid Protein

(2018) Claire Montpellier et al.   GASTROENTEROLOGY

Absence of Persistent Hepatitis E Virus Infection in Antibody-Deficient Patients Is Associated With Transfer of Antigen-Neutralizing Antibodies From Immunoglobulin Products

(2018) Mike Ankcorn et al.   JOURNAL OF INFECTIOUS DISEASES

Analysis of IgG Anti-HEV Antibody Protective Levels During Hepatitis E Virus Reinfection in Experimentally Infected Rhesus Macaques

(2018) Youkyung Choi et al.   JOURNAL OF INFECTIOUS DISEASES

ICTV Virus Taxonomy Profile: Hepeviridae

(2017) Michael A. Purdy et al.   JOURNAL OF GENERAL VIROLOGY

Characterization of the Quasi-Enveloped Hepatitis E Virus Particles Released by the Cellular Exosomal Pathway

(2017) Shigeo Nagashima et al.   JOURNAL OF VIROLOGY

Low hepatitis E virus RNA prevalence in a large-scale survey of United States source plasma donors

(2017) Nathan J. Roth et al.   TRANSFUSION

Hepatitis E virus derived from different sources exhibits different behaviour in virus inactivation and/or removal studies with plasma derivatives

(2016) Mikihiro Yunoki et al.   BIOLOGICALS

Inactivation and removal of Zika virus during manufacture of plasma-derived medicinal products

(2016) Johannes Blümel et al.   TRANSFUSION

Hepatitis E viral loads in plasma pools for fractionation

(2016) Sally A. Baylis et al.   TRANSFUSION

Hepatitis E virus and the safety of plasma products: investigations into the reduction capacity of manufacturing processes

(2015) Maria R. Farcet et al.   TRANSFUSION

The evolution of down-scale virus filtration equipment for virus clearance studies

(2014) Andreas Wieser et al.   BIOTECHNOLOGY AND BIOENGINEERING

Hepatitis E virus egress depends on the exosomal pathway, with secretory exosomes derived from multivesicular bodies

(2014) S. Nagashima et al.   JOURNAL OF GENERAL VIROLOGY

Hepatitis E Virus (HEV) Strains in Serum Samples Can Replicate Efficiently in Cultured Cells Despite the Coexistence of HEV Antibodies: Characterization of HEV Virions in Blood Circulation

(2010) M. Takahashi et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Persistent Carriage of Hepatitis E Virus in Patients with HIV Infection

(2009) Harry R. Dalton et al.   NEW ENGLAND JOURNAL OF MEDICINE

Intravenous immunoglobulin G: trends in production methods, quality control and quality assurance

(2009) M. Radosevich et al.   VOX SANGUINIS

A new liquid intravenous immunoglobulin with three dedicated virus reduction steps: virus and prion reduction capacity

(2008) G. Poelsler et al.   VOX SANGUINIS

Extent of hepatitis E virus elimination is affected by stabilizers present in plasma products and pore size of nanofilters

(2008) M. Yunoki et al.   VOX SANGUINIS